For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes.

More severe visual symptoms among women aged 46-55 years may be attributed to menopause-related visual changes.

OCT, and visual function data may best guide treatment decisions for cataract and improve lens opacity grading.

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

Higher exposure to air pollution increases the risk for Parkinson disease (PD), according to a study published online Sept. 16 in JAMA Network Open. Brittany Kr ...

Peripheral neuropathy and hearing loss are both common in older patients and seem to be independently and additively related to premature mortality.

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx (bimekizumab-bkzx) to include 3 new indications.